Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
TAVIPSYCH
2 other identifiers
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to examine the neuropsychological effects of transvascular aortic valve implantation (TAVI). Patients undergoing TAVI usually suffer from congestive heart failure and low cardiac output which may limit their cognitive abilities. TAVI results in significant improvements in cardiac function and therefore may improve cognitive functions. However, TAVI may also be associated with stroke and may therefore have a negative impact on cognition. Therefore, in this study the investigators wish to perform a battery of standardized neuropsychological tests before and after TAVI to test the net effects of TAVI on cognitive performance over time. The investigators plan to include all patients planned to have TAVI in the study and to test them before, 3,7, 30 and 360 days post TAVI with a standardized battery of test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2012
CompletedFirst Posted
Study publicly available on registry
July 24, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedAugust 16, 2016
August 1, 2016
2 years
July 16, 2012
August 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
net change in neuropsychological tests between baseline and day 180 from TAVI
The study will assess changes in cognitive performance between baseline (prior to TAVI) and 180 days after TAVI
180 days
Secondary Outcomes (1)
net difference between cognitive measures before TAVI and at day 30 after TAVI
30 days
Study Arms (1)
TAVI
patients with significant aortic stenosis that are candidates for transvascular aortic valve implantation
Interventions
Eligibility Criteria
All patients with severe aortic stenosis that are candidates for TAVI
You may qualify if:
- All patients with severe aortic stenosis that are candidates for TAVI
- Able to perform the testing
- Able to sign informed consent
You may not qualify if:
- Language barriers precluding the administration of the testing
- Existing dementia
- Existing disease limiting life expectancy to less than 180 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Center
Jerusalem, 91120, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronen R Leker, MD
Hadassah Medical Organization
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director - Stroke Center
Study Record Dates
First Submitted
July 16, 2012
First Posted
July 24, 2012
Study Start
September 1, 2012
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
August 16, 2016
Record last verified: 2016-08